Smartwatch Tracking of Movement in People With Parkinson's Disease
Tests a smartwatch app for tracking movement in adults with Parkinson's disease.
Plain-language title generated from the registry record
Registry title: SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's Disease
Key facts
- Where
- London, CanadaSee the 2 sites
Where in Canada
- London Health Sciences CenterLondon, CanadaNo longer taking part
- London Health Sciences Center.London ,OntarioLondon, CanadaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Western University
- Trial code
- NCT07066163
- Record updated
- 15 July 2025
- Original description
This study aims to evaluate whether wearable technology can improve the management of motor symptoms in people with Parkinson's disease (PD) who experience motor fluctuations throughout the day. The project will use a smartwatch and mobile app (KinesiaU) to continuously track movement, allowing for more responsive and personalized treatment compared to traditional monitoring methods.Read full original descriptionShow less
SMART-PD: Evaluating the Impact of Smartphone-Based Wearable Technology on Motor Symptoms and Quality of Life in People With Parkinson's Disease
This study aims to evaluate whether wearable technology can improve the management of motor symptoms in people with Parkinson's disease (PD) who experience motor fluctuations throughout the day. The project will use a smartwatch and mobile app (KinesiaU) to continuously track movement, allowing for more responsive and personalized treatment compared to traditional monitoring methods.
In this pilot randomized controlled trial, 32 participants will be assigned to either:
A control group receiving standard care, or
A wearable device group receiving standard care plus using the smartwatch.
Outcomes will be assessed over a 4-week period, focusing on changes in motor function, quality of life, and self-management. The study will also examine feasibility, adherence, and data quality.
If successful, this trial will provide critical evidence for integrating wearable devices into routine clinical care for PD, paving the way for larger efficacy trials and more patient-centered care strategies.
Inclusion: Meet criteria for Parkinson's disease using MDS Clinical Diagnostic Criteria for Parkinson's Disease; Presence of Motor fluctuations based on movement disorder neurologist assessment; Motor ability to use the wearable device and access the wearable device application; Cognitively ability to do ADL's and use the wearable device and access the wearable device application based on clinician's judgment; Knowledge of English to enter medication details in the wearable device application.
Exclusion: Atypical Parkinsonian disorder or other causes of Parkinsonism; Physical barriers in using the wearable device; Inability to read or write English.